The research proposed here will test the hypothesis that a critical gene encoded within the 300 kbp Yeast Artificial Chromosome (YAC) spanning the anonymous polymorphic locus D5S89 on human chromosome 5q3l, is inactivated in a subset of pre leukemic myelodysplasias (MDS) and acute myelogenous leukemias (AMLs). Acquired partial deletions of the long arm of chromosome 5 (5q-) are seen frequently in AMLs and MDS. Considerable evidence suggests that the 5q anomaly occurs in a myeloid precursor cell. Patients who undergo chemotherapy for primary malignancies of the ovaries or breast are at nine to twelve-fold increased risk for secondary MDS/AML. Fifty-percent of these cases present with a 5q- chromosome. Presence of the 5q deletion is a marker for poor prognosis in both de novo and secondary AML and MDS. Identification of a common deleted region at 5q31 in all of these cases, suggests that loss of a critical gene coupled mutation of the remaining allele contributes to leukemogenesis. The following lines of evidence suggest that the 300 kbp YAC harbors the critical gene: (i) the polymorphic D5S89 locus is consistently deleted in every single case of informative MDS and AML carrying the 5q- chromosome, although the cytogenetic limits of these deletions vary; (ii) the D5S89 is interrupted by Long Interspersed Nuclear Element (LINE) sequences on a marker chromosome of the AML cell line HL60; and (iii) Fluorescent in situ hybridization of metaphases from a myelodysplasia patient, with sequences representing 300 kbp of this locus, revealed deletion from the 5q-chromosome and interruption by inversion/duplication of the """"""""normal chromosome 5"""""""". This proposal describes experiments to isolate and characterize the myeloid tumor suppressor gene.
The specific aims of this project are: I. Narrow down the critical region of loss further; II. Isolate cDNAs encoded within the critical region; and III. Identify the MDS/AML candidate gene/s from the cDNAs and search for somatic mutation on the remaining alleles in cases of 5q- MDS and AML.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Mammalian Genetics Study Section (MGN)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas MD Anderson Cancer Center
Other Basic Sciences
Other Domestic Higher Education
United States
Zip Code
Hejlik, Daniel P; Nagarajan, Lalitha (2005) Deletion of 5q in myeloid leukemia cells HL-60: an L1 element-mediated instability. Cancer Genet Cytogenet 156:97-103
Guo, Wei; Chan, Agnes Pui-Yee; Liang, Hong et al. (2002) A human Mix-like homeobox gene MIXL shows functional similarity to Xenopus Mix.1. Blood 100:89-95
Castro, P D; Liang, J C; Nagarajan, L (2000) Deletions of chromosome 5q13.3 and 17p loci cooperate in myeloid neoplasms. Blood 95:2138-43
Zavadil, J; Svoboda, P; Liang, H et al. (1999) An antisense transcript to SMAD5 expressed in fetal and tumor tissues. Biochem Biophys Res Commun 255:668-72
Liang, J C; Ning, Y; Wang, R Y et al. (1999) Spectral karyotypic study of the HL-60 cell line: detection of complex rearrangements involving chromosomes 5, 7, and 16 and delineation of critical region of deletion on 5q31.1. Cancer Genet Cytogenet 113:105-9
Ning, Y; Liang, J C; Nagarajan, L et al. (1998) Characterization of 5q deletions by subtelomeric probes and spectral karyotyping. Cancer Genet Cytogenet 103:170-2
Castro, P D; Fairman, J; Nagarajan, L (1998) The unexplored 5q13 locus: a role in hematopoietic malignancies. Leuk Lymphoma 30:443-8
Hejlik, D P; Kottickal, L V; Liang, H et al. (1997) Localization of SMAD5 and its evaluation as a candidate myeloid tumor suppressor. Cancer Res 57:3779-83